27

2

Logo

Imageens

Company | France
1

followers

Primary tabs

About your organization

Imageens is developing an AI-enabled medical image analysis platform that augments doctors' capabilities to deliver precision and personalized medicine in cardiovascular health.

 

By applying AI and biomechanical modeling to cardiovascular MRI data, our platform allows doctors to seamlessly extract valuable medical insights, which inform treatment decisions for high unmet need cardiovascular diseases (CVD).

 

Imageens' first target CVD is severe assymptomatic carotid stenosis, a disease affecting 5-10% of the population over 65 (~1.5Mn prevalence in EU5 & US) and causing 15-20% of strokes.

 

For assymptomatic carotid stenosis patients, operatory decisions are difficult because the stroke risk for individual patients is highly variable and there is currently no way to know where each patients lies on the "risk spectrum". Therefore, vascular surgeons' currently base their decisions on personal judgement which leads to errors in who gets operated, unecessary costs, and/or avoidable deaths. 

 

Our platform will enable vascular surgeons to accurately predict the individualized stroke risk for each patient, and thus make a precise and personalized decision to operate the patient or not. This improved decision making will allow the healthcare system to save costs (each stroke costs EUR ~75'000) and patient lives (stroke is the #2 cause of death in Europe). We estimate the market size of this solution to be ~$450-900Mn in revenues per year.

Network (0)

There are no organizations in the network.

Recent activity

You are not connected

A certain number of contents are hidden from you and you do not benefit from the linking functionalities.

Log in or register to access to the entire contents and functionnalities. Subscription is quick and free.